Studies from Oregon Health & Science University (OHSU) Provide New Data on Lung Cancer (Angiotensin receptor blockade and stereotactic body radiation therapy for early stage lung cancer ARB & SBRT for early stage lung cancer).

MLA

“Studies from Oregon Health & Science University (OHSU) Provide New Data on Lung Cancer (Angiotensin Receptor Blockade and Stereotactic Body Radiation Therapy for Early Stage Lung Cancer ARB & SBRT for Early Stage Lung Cancer).” Drug Week, Dec. 2023, p. 1439. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=174242218&authtype=sso&custid=ns315887.

APA

Studies from Oregon Health & Science University (OHSU) Provide New Data on Lung Cancer (Angiotensin receptor blockade and stereotactic body radiation therapy for early stage lung cancer ARB & SBRT for early stage lung cancer). (2023). Drug Week, 1439.

Chicago

“Studies from Oregon Health & Science University (OHSU) Provide New Data on Lung Cancer (Angiotensin Receptor Blockade and Stereotactic Body Radiation Therapy for Early Stage Lung Cancer ARB & SBRT for Early Stage Lung Cancer).” 2023. Drug Week, December, 1439. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=174242218&authtype=sso&custid=ns315887.